860575P

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0)

Avanti Research^™ - A Croda Brand 860575P, powder

• 同義詞: D-lactosyl-β1-1′-N-octanoyl-L-threo-sphingosine
• 經驗公式（希爾表示法）: C₃₈H₇₁NO₁₃
• CAS號碼: 939036-94-9
• 分子量：: 749.97
• MDL號碼: MFCD28143570
• 分類程式碼代碼: 12352211
• NACRES: NA.25

屬性

• 形狀: powder
• 包裝: pkg of 1 × 1 mg (860575P-1mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 860575P
• 脂質類型: sphingolipids
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: CCCCCCCCCCCCC/C=C/[C@@](O)([H])[C@@]([H])(NC(CCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O[C@H](O2)[C@H](O)[C@@H](O)[C@H]([C@H]2CO)O
• InChI 密鑰: JUCWRRXMPGRQOG-CKTHHAJGSA-N

描述

一般說明

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a synthetic glycosphingolipid (GSL) with nonnatural stereochemistry.

應用

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) may be used to disrupt brain-derived neurotropic factor (BDNF)-induced integrin clustering.[1]

生化／生理作用

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a caveolar uptake inhibitor, which blocks SV40 virus infection. It also prevents E1-integrin activation and downstream signaling.[1] C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) can deter the aggregation of lipids and proteins into glycosphingolipids (GSLs) and cholesterol-enriched microdomains (rafts) at the plasma membrane (PM).

包裝

5 mL Amber Glass Screw Cap Vial (860575P-1mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3